The term "standard saline" (NS or N/S) refers to a 0.90 percent w/v NaCl solution of around 300 mOsm/L or 9.0 g per litre. This solution is also known as physiological saline or isotonic saline, but none of these terms is scientifically correct. NS is often used in intravenous drips (IVs) for patients that are unable to drink fluids or who have developed or are at risk of experiencing dehydration or hypovolemia. Saline is sometimes used to flush wounds and skin abrasions in medical settings. When applied, normal saline will not burn or sting. I.V. treatment, intravenously providing extra water to rehydrate patients, or supplying a patient's normal water and salt needs ("maintenance" needs) who is unable to take them by mouth often uses saline.
Dextrose (also known as D-glucose, corn sugar, starch sugar, blood sugar, and grape sugar) is the most abundant sugar in nature, and it can be found either free (monosaccharide form) or chemically associated with other sugars. It can be found in large amounts in honey, fruits, and berries in the Free State. It can be found in starch, cellulose, and glycogen as a polymer of anhydrodextrose units. Sucrose is a dextrose and fructose disaccharide.
Dextrose is made commercially by hydrolyzing starch to produce white crystalline sugars that are either anhydrous (C6H12O6) or hydrated (C6H12O6) (C6H12O6H2O). At 50°C, dextrose hydrate separates from condensed solutions due to one molecule of water of crystallisation per molecule of sugar. Anhydrous D-glucose has no crystallisation water and separates at 50-115°C. If crystallisation is carried out at temperatures above 110-115°C, another anhydrous form, B-D-glucose, separates.
· When sodium extraction needs to be reduced, dextrose solution is used.
· For increased urine flow, a dextrose solution with a concentration of 10-15% is used.
· In an emergency, such as a raemdrhage crash, a dextrose solution containing 5% normal salmicis is used to restore fluid volume in circulation.
· When a significant amount of sodium has been lost by vomiting, gastric or intestinal duodenal aspiration, or analimucationfistuala, saline solution is used.
· In part of the feeding, dextrose monohydrate is used as a supplement to cow's milk.
The market is expected to rise due to the rising prevalence of chronic diseases. Cancer is expected to rise by 70% in the next few decades, according to projections. Stomach cancer is one of the top five cancers, according to the World Cancer Research Fund International, with 952,000 new cases diagnosed in 2012. These patients are unable to eat or drink and must rely on total parenteral nutrition (TPN) to live.
Intravenous (IV) solutions are fluids that are applied directly into the venous circulation of a patient. These fluids are sterile and are used to protect patients who are severely dehydrated. In the industry, there are a variety of IV options to choose from. Many companies produce packaged intravenous fluids, drugs, or compounds that can be combined with sterile water to make an intravenous administration solution. The demand for intravenous (IV) solution is projected to hit USD 11,511.2 million by 2022, with a compound annual growth rate (CAGR) of 7.69 percent from 2016 to 2022. The growing prevalence of chronic diseases, as well as the rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer, are driving market growth. Thus, due to demand it is best to invest in this project.
Few Indian Major Players
· Pfizer Healthcare India Pvt. Ltd.
· Pfizer Ltd.
· Pharmacia Healthcare Ltd.
· Shree Krishna Keshav Laboratories Ltd.
· Vikrant Pharmaceuticals Ltd.
· Wockhardt Health Care Ltd.
